The objectives of this project are: 1) to comprehensively characterize a large national cohort of patients with suspected myocarditis, their clinical phenotype, care management, blood and imaging biomarkers, epidemiological, environmental and genetic data; 2) to retrospectively validate the accuracy of the new hsa-RNA-Chr8:96 biomarker for the diagnosis of myocarditis compared to conventional diagnosis; 3) to identify acquired and inherited mutations, and their interaction with the environment, which explain the susceptibility to myocarditis, its severity and response to treatment; 4) to study the lower incidence in women and the influence of age, considering socio-health and genetic factors.
Acute chest pain: pericardial or pseudo-ischemic.
Dyspnea on exertion or at rest for up to 3 months.
Dyspnea on exertion or at rest for 3 months - 1 year.
Unexplained palpitations / arrhythmias, sudden death recovered.
None